share_log

中国抗体-B(03681.HK)拟3月25日举行董事会会议考虑及批准全年业绩

China Antibody-B (03681.HK) plans to hold a board meeting on March 25 to consider and approve annual results

Gelonghui Finance ·  Mar 12 06:29

Gelonghui March 12 | China Antibody-B (03681.HK) announced that a board meeting will be held on March 25, 2024 (Monday) to consider and approve the Group's annual results and announcements for the year ended December 31, 2023, and to deal with other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment